The role of Chromium III in the organism and its possible use in diabetes and obesity treatment

Journal Title: Annals of Agricultural and Environmental Medicine - Year 2014, Vol 21, Issue 2

Abstract

introduction. Diabetes and obesity are diseases characterized by their increasing incidence every year. When comparing with healthy subjects, the serum levels of chromium (Cr) are lowered in these two diseases. Several studies conducted in laboratory animals with experimentally- induced diabetes demonstrated that supplementation with chromium ions (III) decreased glucose concentration in the blood, reduced the probability of atherosclerosis and heart attack, lowered the levels of cholesterol and low density lipoprotein (LDL). The Importance of chromium is actually challenged due to lack of clear manifestations of Cr deficiency in humans and animals. objective. The aim of this review was to present current knowledge about Cr its role in the organism and possible mechanisms of its action also in metabolic disorders such as diabetes or obesity. state of knowledge. In the last decade, Cr was established to be rather a beneficial than essential trace element in mammals, and has gained popularity as a nutritional supplement and a component of many multivitamin/mineral formulations, fortified food and energy drinks. Cr supplements are widespread for diabetes and obesity treatment, despite conflicting reports on its efficacy. It was suggested that Cr shows a beneficial influence upon glucose and lipid disturbances. conclusions. The recent clinical trials provided evidence both in favor and against the importance of Cr in healthy and ill organisms. Unfortunately, also the molecular mechanism by which chromium affects glucose and lipid metabolism is still unclear. Beneficial effects of diet supplementation with different sources of Cr 3+ can be potentially explained by rather pharmacological than nutritional effects.

Authors and Affiliations

Sławomir Lewicki, Robert Zdanowski, Małgorzata Krzyżowska, Aneta Lewicka, Bogdan Dębski, Marcin Niemcewicz, Mariusz Goniewicz

Keywords

Related Articles

Toxin producing micromycetes on fruit, berries, and vegetables.

In 1999-2001 the investigations on mycological state of stored and sold fruit, berries, and vegetables grown in Lithuania and imported from other countries were performed. The samples of foodstuff were taken from storeho...

Cytomegalovirus (CMV) – a new prospect for prevention

Human cytomegalovirus (HCMV), a member of the Betaherpesvirinae subfamily of the Herpesviridae family, is a widespread pathogen. CMV is a virus usually completely harmless to healthy people; nevertheless, it is still a m...

Microarrays – new possibilities for detecting biological factors hazardous for humans and animals, and for use in environmental protection

Both the known biological agents that cause infectious diseases, as well as modified (ABF-Advanced Biological Factors) or new, emerging agents pose a significant diagnostic problem using previously applied methods, both...

Work-related musculoskeletal disorders among dentists - a questionnaire survey.

Dentists at work are susceptible to the development of health disorders. Bad working habits, repetitive tasks and uncomfortable posture contribute to musculoskeletal disorders (MSDs), stress and loss of production. The p...

Questions and commentary on the article ‘Daily changes of peak expiratory flow and respiratory symptom occurrence around a soy processing factory’

Questions and commentary on the article ‘Daily changes of peak expiratory flow and respiratory symptom occurrence around a soy processing factory’

Download PDF file
  • EP ID EP80788
  • DOI -
  • Views 93
  • Downloads 0

How To Cite

Sławomir Lewicki, Robert Zdanowski, Małgorzata Krzyżowska, Aneta Lewicka, Bogdan Dębski, Marcin Niemcewicz, Mariusz Goniewicz (2014). The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Annals of Agricultural and Environmental Medicine, 21(2), 331-335. https://europub.co.uk/articles/-A-80788